Professor John Hardy, a world-leading dementia researcher and molecular biologist at University College London, said the drug ‘represents the beginning of the end’.Professor John Hardy, a world-leading dementia researcher and molecular biologist at University College London, said the drug ‘represents the beginning of the end’.Read MoreHealth News | Mail Online